Moneycontrol PRO
HomeNewsBiotechnology

Biotechnology

Jump to
  • Scientists find new bacteria that survive by breathing electricity, not oxygen

    The bacteria use a natural molecule called naphthoquinone. This acts like a tiny shuttle for electrons inside the cell.

  • Bacteria capable of surviving harsh space conditions discovered on China’s space station

    Bacteria capable of surviving harsh space conditions discovered on China’s space station

    The bacterium, Niallia tiangongensis, was discovered on hardware surfaces within the Tiangong space station.

  • 26 new bacterial species discovered in NASA cleanrooms hold clues to space survival

    26 new bacterial species discovered in NASA cleanrooms hold clues to space survival

    The finding was by a group of researchers from NASA's Jet Propulsion Laboratory and in partnership with scientists from across India and Saudi Arabia.

  • After de-extinction of dire wolves, Elon Musk wishes to have this prehistoric animal as a pet

    After de-extinction of dire wolves, Elon Musk wishes to have this prehistoric animal as a pet

    Colossal Biosciences was able to successfully breed three wolf pup-like offspring of the extinct dire wolf by genetic engineering, igniting debate and enthusiasm on the possibility of de-extinction and designer species.

  • Are we closer to reviving mammoths? Scientists create the first-ever woolly mouse with thick fur

    Are we closer to reviving mammoths? Scientists create the first-ever woolly mouse with thick fur

    Colossal Biosciences announces the creation of the Colossal Woolly Mouse, a genetically engineered mouse with woolly mammoth traits, bringing scientists closer to de-extinction and revival of the woolly mammoth.

  • Meet 'Polo Super Ponies': World’s first genetically modified horses bred for 'explosive speed' in Argentina

    Meet 'Polo Super Ponies': World’s first genetically modified horses bred for 'explosive speed' in Argentina

    Scientists in Argentina have made history by creating the world's first genetically modified horses, designed to be faster and more agile.

  • Chinese scientists create mice with two dads without any female DNA—know how

    Chinese scientists create mice with two dads without any female DNA—know how

    Chinese scientists achieve genetic breakthrough by breeding baby mice using DNA from two male parents, opening new possibilities in reproductive science and gene editing technology.

  • Cabinet approves bio-manufacturing, biofoundry scheme with outlay of Rs 9,197 cr

    Cabinet approves bio-manufacturing, biofoundry scheme with outlay of Rs 9,197 cr

    The proposed outlay of Rs 9,197 crore will be implemented during the 15th Finance Commission period from 2021-22 to 2025-26.

  • Scientists confirm a mysterious 'third state' beyond life and death; What is it?

    Scientists confirm a mysterious 'third state' beyond life and death; What is it?

    For years, life and death have been seen as opposite forces. Yet, recent discoveries reveal a "third state" beyond these boundaries. These findings challenge long-standing perceptions about life and death, offering new insights into cellular behaviour.

  • Karnataka's biotechnology policy aims to generate 30,000 high-quality jobs by 2029

    Karnataka's biotechnology policy aims to generate 30,000 high-quality jobs by 2029

    Karnataka Biotechnology Policy 2024-2029 aims to facilitate the creation of 300 biotech companies, including 50 innovative firms, supported by a robust incentive package.

  • Karnataka revised biotech policy: Investment subsidy of upto Rs 10 cr; biofoundries in PPP mode

    Karnataka revised biotech policy: Investment subsidy of upto Rs 10 cr; biofoundries in PPP mode

    Karnataka biotechnology draft policy offers investment subsidy of upto 10 crore; fellowship of Rs 50,000 per month for 12 months to graduating students or professionals with experience

  • World Health Day 2023 | Personalized medicine and the future of diagnostics and drug therapy

    World Health Day 2023 | Personalized medicine and the future of diagnostics and drug therapy

    Initiatives like the Human Genome Project and the Genome India Project will help scientists map the prevalence of disease in a population cohort, and to strategize for better outcomes.

  • Panacea Biotec stock spikes on $127.3-million global vaccine orders

    Panacea Biotec stock spikes on $127.3-million global vaccine orders

    Panacea Biotic shares surged on the bourses-NSE and BSE- after the pharmaceutical firm announced on Monday that it had bagged a long-term supply order from UNICEF and Pan American Health Organisation for supply of its pentavalent vaccine Easyfive-TT.

  • Joe Biden to announce new support for US biotech production

    Joe Biden to announce new support for US biotech production

    Joe Biden on Monday signed an executive order implementing the initiative and later, in remarks at the John F. Kennedy Presidential Library in Boston, will address how biotech can help fight cancer.

  • Scientists create synthetic embroys with evidence of beating heart, brain

    Scientists create synthetic embroys with evidence of beating heart, brain

    The lab-created embryos mirror a natural mouse embryo up to 8.5 days after fertilization, containing the same structures.

  • Richcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

    Richcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

    Acquisition of Richcore Lifesciences will give Laurus Labs a foothold in the growing biotechnology sector. Scale-up of the business can be time consuming but can yield meaningful earnings benefits

  • Silver Leaf Oak sells Syngene shares worth Rs 71 cr

    Silver Leaf Oak sells Syngene shares worth Rs 71 cr

    Silver Leaf Oak, a Mauritius-based private equity fund, today sold 12 lakh shares of Syngene International for an estimated over Rs 71 crore through an open market transaction.

  • Donald Trump vows to bring down drug prices, doesn't say how

    Donald Trump vows to bring down drug prices, doesn't say how

    The Republican US president-elect, a wealthy real estate developer who ran a campaign with a populist appeal, did not state in the interview how he would reduce the cost of prescription drugs. Trump previously has suggested he was open to allowing importation of cheaper medicines from overseas.

  • Govt approves 6 new SEZs for IT, biotech

    Govt approves 6 new SEZs for IT, biotech

    The decision was taken by the Board of Approval (BoA), headed by Commerce Secretary Rita Teaotia, at its November 9 meeting, an official said.

  • India witnessing 'jobless' growth: Kiran Mazumdar-Shaw

    India witnessing 'jobless' growth: Kiran Mazumdar-Shaw

    The Chairperson and MD of Biocon Ltd said restrictive e-regulations that try to protect conventional bricks and mortar jobs are an example of this.

  • Biocon ranked among world's top 10 employers in Biotech

    Biocon ranked among world's top 10 employers in Biotech

    The company has moved up to No 9 in 'Science 2016 Top Employer' ranking from No 13 last year, Biocon said in a release.

  • Biocon Q2 net profit of Rs 146.7 cr

    Biocon Q2 net profit of Rs 146.7 cr

    Biotechnology major Biocon today reported a consolidated net profit of Rs 146.7 crore for the second quarter ended September 30, 2016.

  • PepsiCo, Biocon to set up facilities in Karnataka

    PepsiCo, Biocon to set up facilities in Karnataka

    Biotechnology major Biocon has proposed an investment of Rs 1,060 crore for the manufacture of injectables, monoclonal and anti-bodies vaccine at Anekal taluk. It is expected to employ about 750 people, an official release said.

  • Bayer makes global offer to buy Monsanto for USD62 billion

    Bayer makes global offer to buy Monsanto for USD62 billion

    German pharmaceutical and chemical giant Bayer AG on May 23 announced a USD 62-billion all-cash offer to acquire US-based biotechnology major Monsanto Co, which has a significant presence in India

  • Biocon Q4 net spikes 79% to Rs 361 crore

    Biocon Q4 net spikes 79% to Rs 361 crore

    Net sales rose to Rs 970.3 crore for the fourth quarter, up 16.84 percent, from Rs 830.4 crore a year ago, Biocon said in a BSE filing.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347